Dabigatran Etexilate Capsules Recalled Over Impurity Test Failure
Ascend Laboratories is recalling 1,753 cartons of dabigatran etexilate capsules (lot 25141707) due to out-of-specification results in impurity testing during 12-month stability studies.
- Product
- DABIGATRAN ETEXILATE — DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE)
- Category
- Drug
- Distribution
- Distributed nationwide